Mertiva appoints CEO

At a statutory Board meeting following an Extraordinary General Meeting on April 22, 2013 in Mertiva AB (previously Diamyd Medical AB), Andreas Bergsten was appointed as the Chief Executive Officer of the Company.Andreas Bergsten, born in 1967, is currently working as a consultant in finance and management and has, in his capacity as a consultant, primarily worked for venture capital and private equity firms. In the past, Andreas has served as CFO of four different companies and, prior to this, he was employed at Citigroup, initially as a financial analyst and subsequently as a relationship